Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.

Por Cao, H, Kanki, P, Sankalé, J L, Dieng-Sarr, A, Mazzara, G P, Kalams, S A, Korber, B, Mboup, S, Walker, B D
Publicado em 1997

Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line Therapy

Por Chaplin, B., Eisen, G., Idoko, J., Onwujekwe, D., Idigbe, E., Adewole, I., Gashau, W., Meloni, S., Sarr, A.D., Sankalé, J.L., Ekong, E., Murphy, R.L., Kanki, P.
Publicado em 2011